DATE: January 31, 2017
TIME: 10:00am PT/1:00pm ET

Learn from renowned clinical expert, Dr. Michael A. Pfaller, as he discusses the critical role of diagnostics and antimicrobial stewardship in improving patient outcomes and reducing overall healthcare costs.  

Dr. Pfaller will discuss how a robust antimicrobial stewardship program, when coupled with transformative diagnostic tools such as T2MR^® and the T2Candida^® Panel, offers clinicians the opportunity for early, targeted antimicrobial interventions with the potential to improve patient outcomes and reduce healthcare costs. 

Dr. Pfaller will also review current best practices for diagnosing and managing patients at risk for sepsis and provide an overview of forthcoming rapid, highly sensitive, direct-from-blood diagnostics.

Learning Objectives:

• Understand the critical role of diagnostics and antimicrobial stewardship in improving patient outcomes for patients at high risk for sepsis and invasive candidiasis
• Understand the potential of rapid diagnostics, such as the T2Candida^® Panel and T2Dx^® Instrument, to improve patient outcomes and reduce healthcare costs through the timely detection of deadly sepsis pathogens